NeurogesX, Inc.

IN VITRO DIAGNOSTICS ALLIANCES Akers Biosciences Inc. Alere Inc. First Check Diagnostics LLC Akers Biosciences Inc. licensed Alere Inc. 's First Check Diagnostics LLC exclusive US distribut

The task of commercializing a drug alone in Europe is a formidable one for a smaller company, and licensing out European rights avoids many of the operational, regulatory, and commercial challenges. A

Acorda Therapeutics paid NeurogesX $7.9 million up front for a commercial pain therapy and a late-stage, topical pain drug candidate – from which Acorda expects to derive the most value – as NeurogesX

IN VITRO DIAGNOSTICS Alliances Amgen Inc. Transgenomic Inc. Amgen Inc. has penned a deal with Transgenomic Inc. (diagnostics) to develop a CE-IVD test to screen metastatic colorectal cancer pa